Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Springworks Therapeutics Inc (NQ: SWTX ) 31.83 -1.00 (-3.05%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Springworks Therapeutics Inc < Previous 1 2 3 Next > SpringWorks Therapeutics Stock Clears Key Benchmark, Hitting 80-Plus RS Rating August 21, 2024 A Relative Strength Rating upgrade for SpringWorks Therapeutics shows improving technical performance. Via Investor's Business Daily SWTX Stock Earnings: SpringWorks Therapeutics Beats EPS, Beats Revenue for Q2 2024 August 07, 2024 SWTX stock results show that SpringWorks Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace SWTX Stock Earnings: SpringWorks Therapeutics Meets EPS, Beats Revenue for Q1 2024 May 02, 2024 SWTX stock results show that SpringWorks Therapeutics met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace 7 Biotech Stocks to Buy as Sector Rotation Ramps Up March 13, 2024 With digital innovation possibly getting overextended, now’s the time to consider biotech stocks for an incoming rotation. Via InvestorPlace SpringWorks Therapeutics: Q4 Earnings Insights February 27, 2024 Via Benzinga Why SpringWorks Therapeutics Stock (SWTX) Is Nosediving December 05, 2023 SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing of a publ Via Benzinga Analyst Ratings for SpringWorks Therapeutics November 29, 2023 Via Benzinga Analyst Ratings for SpringWorks Therapeutics August 24, 2023 Via Benzinga Analyst Ratings for SpringWorks Therapeutics July 20, 2023 Via Benzinga Why Titan Machinery Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session November 30, 2023 Shares of Titan Machinery Inc. (NASDAQ: TITN) moved lower during Thursday’s trading following weak quarterly results. Via Benzinga La-Z-Boy Posts Upbeat Earnings, Joins Victoria's Secret, Snowflake And Other Big Stocks Moving Higher On Thursday November 30, 2023 U.S. stocks traded mostly higher, with the Dow Jones index gaining around 200 points on Thursday. Via Benzinga Topics Stocks Exposures US Equities The Latest Analyst Ratings for SpringWorks Therapeutics June 06, 2023 Via Benzinga SpringWorks Therapeutics: Q1 Earnings Insights May 03, 2023 Via Benzinga Analyst Expectations for SpringWorks Therapeutics's Future April 20, 2023 Via Benzinga 4 Analysts Have This to Say About SpringWorks Therapeutics December 01, 2022 Via Benzinga Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session November 28, 2023 Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session November 28, 2023 Via Benzinga SpringWorks Catapults 24% On A 'Watershed Moment' In Cancer Treatment November 28, 2023 The company gained FDA approval for Ogsiveo, a treatment for desmoid tumors. Via Investor's Business Daily Exposures Product Safety PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday November 28, 2023 U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday. Via Benzinga Topics Stocks Exposures US Equities Analyst Ratings for SpringWorks Therapeutics November 04, 2022 Within the last quarter, SpringWorks Therapeutics (NASDAQ:SWTX) has observed the following analyst ratings: Via Benzinga Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket November 28, 2023 Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults... Via Benzinga Exposures Product Safety FDA Approves SpringWorks Therapeutics' Lead Therapy As First For Subtype Of Soft Tissue Sarcomas November 28, 2023 The FDA approved SpringWorks Therapeutics Inc's (NASDAQ: SWTX) Ogsiveo (nirogacestat), an oral gamma-secretase inhibitor, for adult patients with progressing desmoid tumors who Via Benzinga Exposures Product Safety HC Wainwright & Co. Maintains Buy Rating for SpringWorks Therapeutics: Here's What You Need To Know November 20, 2023 Via Benzinga What's Going On With Rare Diseases-Focused SpringWorks Therapeutics Stock Today? November 16, 2023 SpringWorks Therapeutics Inc (NASDAQ: SWTX) released topline results from its Phase 2b ReNeu trial evaluating mirdametinib, an investigational MEK inhibitor, in pediatric and adult patients with... Via Benzinga SpringWorks' Investigational Cancer Treatment Is Standard Care, Analyst Unfazed By FDA Update August 24, 2023 In March, the FDA issued SpringWorks Therapeutics Inc (NASDAQ: SWTX) with a Form 483 letter due to a failure to ensure that the analysis of an exploratory endpoint in the Phase 3 DeFi trial, which... Via Benzinga Exposures Product Safety Get In Now. 7 Stocks That Are Set to Soar. April 13, 2023 While it’s always difficult to determine which stocks to buy might break out imminently, speculators should watch these ideas. Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2022 December 01, 2022 Via Benzinga How to Trade the High-Growth Biotech Sector in the Midst of a Bear Market November 23, 2022 Biotech is an exciting and emerging space that’s attracted increasing investor interest in recent years. Via Benzinga SpringWorks Therapeutics: Q3 Earnings Insights November 03, 2022 SpringWorks Therapeutics (NASDAQ:SWTX) reported its Q3 earnings results on Thursday, November 3, 2022 at 06:30 AM. Here's what investors need to know about the announcement. Via Benzinga Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday September 13, 2022 Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split. Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.